ArticleAmerican journal of cancer research2023

Combined inhibition of PARP and ATR synergistically potentiates the antitumor activity of HER2-targeting antibody-drug conjugate in HER2-positive cancers.

Yongpeng Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.